An issue of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) debt fell 0.4% as a percentage of its face value during trading on Thursday. The high-yield debt issue has a 5.125% coupon and is set to mature on July 1, 2022. The debt is now trading at $99.88 and was trading at $102.00 one week ago. Price moves in a company’s debt in credit markets sometimes anticipate parallel moves in its stock price.

Several equities research analysts recently commented on ACHC shares. Mizuho boosted their price target on Acadia Healthcare from $57.00 to $60.00 and gave the company a “buy” rating in a research note on Friday, July 28th. UBS AG reissued a “positive” rating and issued a $60.00 price target (up previously from $54.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Craig Hallum reissued a “buy” rating and issued a $65.00 price target (up previously from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Deutsche Bank AG boosted their price target on Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a research note on Monday, July 31st. Finally, BidaskClub cut Acadia Healthcare from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Two analysts have rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company’s stock. Acadia Healthcare has an average rating of “Hold” and an average target price of $45.15.

Shares of Acadia Healthcare Company, Inc. (NASDAQ ACHC) traded up $0.34 during trading on Friday, reaching $29.84. The company’s stock had a trading volume of 2,018,609 shares, compared to its average volume of 1,353,085. The company has a market capitalization of $2,590.00, a PE ratio of 12.14, a P/E/G ratio of 1.03 and a beta of 0.89. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 1.30. Acadia Healthcare Company, Inc. has a 52-week low of $26.92 and a 52-week high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.07). The company had revenue of $716.70 million for the quarter, compared to the consensus estimate of $728.86 million. Acadia Healthcare had a return on equity of 8.57% and a net margin of 6.07%. The firm’s revenue for the quarter was down 2.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.58 EPS. analysts expect that Acadia Healthcare Company, Inc. will post 2.23 EPS for the current year.

In other news, CEO Joey A. Jacobs sold 500,000 shares of the stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $25,345,000.00. Following the completion of the sale, the chief executive officer now directly owns 201,496 shares of the company’s stock, valued at $10,213,832.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Christopher L. Howard sold 53,713 shares of the stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $2,722,711.97. Following the completion of the sale, the executive vice president now directly owns 147,286 shares of the company’s stock, valued at $7,465,927.34. The disclosure for this sale can be found here. Insiders have sold 1,824,040 shares of company stock valued at $92,460,588 in the last ninety days. Company insiders own 11.10% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of ACHC. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Acadia Healthcare by 11.1% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock valued at $134,000 after acquiring an additional 270 shares during the period. C M Bidwell & Associates Ltd. bought a new stake in shares of Acadia Healthcare in the second quarter valued at approximately $205,000. Riverhead Capital Management LLC bought a new stake in shares of Acadia Healthcare in the second quarter valued at approximately $209,000. Paloma Partners Management Co bought a new stake in shares of Acadia Healthcare in the first quarter valued at approximately $217,000. Finally, Rathbone Brothers plc bought a new stake in shares of Acadia Healthcare in the third quarter valued at approximately $223,000.

TRADEMARK VIOLATION NOTICE: This article was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/11/18/acadia-healthcare-company-inc-achc-debt-trading-0-4-lower.html.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.